Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer.
Intra arterial therapies are radiologic procedures that block liver cancer blood supply.
The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Trans-arterial embolization (TAE),
Transarterial chemoembolization (TACE),
Transarterial radioembolization (TARE)
Drug-eluting beads chemoembolization (DEB-TACE)
Disqualifiers
shunt of gastro intestinal arteries that cannot be embolized
metastasis spread outside of the liver
liver failure
Trial population
The participants will be selected from patients that are followed at Radiology Department of IRCCS Azienda Ospedaliero-Universitaria hospital in the city of Bologna.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Type and size of the injury
Type and size of the injury
Time frame
From enrollment to the end of treatment at 9 years2
Radiological response to therapy
Radiological response to therapy
Time frame
From enrollment to the end of treatment at 9 years3
Post treatment complications
Post treatment complications
Time frame
From enrollment to the end of treatment at 9 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov